Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


16.01.2017

1 Brain
29 Clin Nucl Med
2 J Cereb Blood Flow Metab
3 J Nucl Cardiol
12 J Nucl Med
2 Nuklearmedizin
1 Phys Med Biol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain

  1. PONTECORVO MJ, Devous MD Sr, Navitsky M, Lu M, et al
    Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Brain. 2017 Jan 11. pii: aww334. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  2. CHENG X, Zhu W, Cui R
    Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.
    Clin Nucl Med. 2016;41:953-955.
    PubMed     Text format     Abstract available

  3. WILHELM T, Winkens T, Kunze A, Freesmeyer M, et al
    131I and 124I Accumulation in a Thymic Cyst.
    Clin Nucl Med. 2016;41:972-974.
    PubMed     Text format     Abstract available

  4. VAMADEVAN S, Le K, Bui C, Mansberg R, et al
    Prostate-Specific Membrane Antigen Uptake in Small Cleaved B-Cell Follicular Non-Hodgkin Lymphoma.
    Clin Nucl Med. 2016;41:980-981.
    PubMed     Text format     Abstract available

  5. BERMO MS, Leung A, Behnia F
    A Case of Nasal Merkel Cell Carcinoma Draining to a Buccinator Sentinel Lymph Node.
    Clin Nucl Med. 2016;41:e480-e481.
    PubMed     Text format     Abstract available

  6. TOLENTINO JC, Schmidt JJ, Schmidt GJ, Mesquita CT, et al
    Mental Stress-Induced Myocardial Ischemia Related to Generalized Anxiety Disorder in a Patient With Acute Coronary Syndrome and Normal Coronary Arteries.
    Clin Nucl Med. 2016;41:e487-e490.
    PubMed     Text format     Abstract available

  7. SHETTY D, Loh H, Bui C, Mansberg R, et al
    Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
    Clin Nucl Med. 2016;41:776-8.
    PubMed     Text format     Abstract available

  8. QIN C, Wu Z, Li J, Sun X, et al
    Differences in Uptake of 18F-FDG and 11C-Choline in a Case of Acute Myeloid Leukemia.
    Clin Nucl Med. 2016;41:799-801.
    PubMed     Text format     Abstract available

  9. CHEN L, Chen Y, Huang Z, Cai L, et al
    Intense 99mTc-MDP and 18F-NaF Activity in Long-standing Subcutaneous Implants.
    Clin Nucl Med. 2016;41:812-4.
    PubMed     Text format     Abstract available

  10. VAMADEVAN S, Shetty D, Le K, Bui C, et al
    Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor.
    Clin Nucl Med. 2016;41:804-6.
    PubMed     Text format     Abstract available

  11. DE MARINI P, Laplace A, Matuszak J, Fornecker LM, et al
    Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
    Clin Nucl Med. 2016;41:802-3.
    PubMed     Text format     Abstract available

  12. JADOUL A, Lovinfosse P, Weekers L, Delanaye P, et al
    The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function.
    Clin Nucl Med. 2016;41:683-7.
    PubMed     Text format     Abstract available

  13. AHN BC
    Reinforcing the Ability of 99mTcO4 Scintigraphy for Identifying Differentiated Thyroid Cancer by TSH Stimulation.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  14. BAL C, Yadav MP, Ballal S
    Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC: A Proof-of-Principle Application.
    Clin Nucl Med. 2016;41:e386-7.
    PubMed     Text format     Abstract available

  15. BRABANDER T, Teunissen J, Kwekkeboom D
    Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
    Clin Nucl Med. 2017;42:15-19.
    PubMed     Text format     Abstract available

  16. D'ESTANQUE E, Chambert B, Moranne O, Kotzki PO, et al
    18F-Florbetaben: A New Tool for Amyloidosis Staging?
    Clin Nucl Med. 2017;42:50-53.
    PubMed     Text format     Abstract available

  17. HOGAN MP, Osborne J, Ulaner GA
    FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.
    Clin Nucl Med. 2016;41:995-997.
    PubMed     Text format     Abstract available

  18. ROWE SP, Gorin MA, Javadi MS, Allaf ME, et al
    Evaluation of a Large Renal Mass Using 99mTc-MIBI SPECT/CT in a Patient With Chronic Kidney Disease.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001533.
    PubMed     Text format     Abstract available

  19. LIU CJ, Lu MY, Liu YL, Ko CL, et al
    Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001529.
    PubMed     Text format     Abstract available

  20. PAPADAKIS GZ, Millo C, Sadowski SM, Karantanas AH, et al
    Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001527.
    PubMed     Text format     Abstract available

  21. POLOM W, Gruszecka A, Markuszewski M, Cytawa W, et al
    Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods: Reply.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001523.
    PubMed     Text format    

  22. PARK MJ, Oh JS, Roh JL, Kim JS, et al
    18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001515.
    PubMed     Text format     Abstract available

  23. NORITAKE M, Narui K, Kaneta T, Sugae S, et al
    Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001497.
    PubMed     Text format     Abstract available

  24. NOTO B, Weckesser M, Buerke B, Pixberg M, et al
    Gastrointestinal Stromal Tumor Showing Intense Tracer Uptake on PSMA PET/CT.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001491.
    PubMed     Text format     Abstract available

  25. KASHIWAGI N, Enoki E, Hosokawa C, Sakaguchi K, et al
    18F-FDG PET/CT Features of Chronic Sclerosing Sialadenitis Presenting as Localized IgG4-Related Disease.
    Clin Nucl Med. 2017;42:131-132.
    PubMed     Text format     Abstract available

  26. AHN BC
    Re: Precise Localization of Occult Gastrointestinal Hemorrhage Using Dynamic SPECT/CT.
    Clin Nucl Med. 2017;42:161.
    PubMed     Text format    

  27. PATEL DR, Kamat BH, Farwell MD
    Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  28. ASMAR A, Simonsen L, Svolgaard B, Bulow J, et al
    Unexpected Diffuse 18F-NaF Uptake in the Lung Parenchyma in a Patient With Severe Hypercalcemia Due to Myelomatosis.
    Clin Nucl Med. 2017;42:68-69.
    PubMed     Text format     Abstract available

  29. XIE P, Shao F, Zhuang H
    Primary Neuroblastoma Involving Spinal Canal.
    Clin Nucl Med. 2016;41:986-988.
    PubMed     Text format     Abstract available

  30. MEYER M, Fernandez P, Zanotti-Fregonara P
    18F-FDG Imaging of Chronic Inflammation Associated With Promontofixation of the Uterus.
    Clin Nucl Med. 2017;42:42-43.
    PubMed     Text format     Abstract available


    J Cereb Blood Flow Metab

  31. POTTIER G, Gomez-Vallejo V, Padro D, Boisgard R, et al
    PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats.
    J Cereb Blood Flow Metab. 2017 Jan 1:271678X16685105.
    PubMed     Text format     Abstract available

  32. GANZ M, Feng L, Hansen HD, Beliveau V, et al
    Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands.
    J Cereb Blood Flow Metab. 2017 Jan 1:271678X16686092.
    PubMed     Text format     Abstract available


    J Nucl Cardiol

  33. FERREIRA MJ, Oliveira-Santos M, Silva R, Gomes A, et al
    Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT.
    J Nucl Cardiol. 2017 Jan 9. doi: 10.1007/s12350-016-0776.
    PubMed     Text format     Abstract available

  34. HAMMAD B, Evans NR, Rudd JH, Tawakol A, et al
    Molecular imaging of atherosclerosis with integrated PET imaging.
    J Nucl Cardiol. 2017 Jan 11. doi: 10.1007/s12350-016-0766.
    PubMed     Text format     Abstract available

  35. GIMELLI A, Liga R, Clemente A, Marras G, et al
    Left ventricular eccentricity index measured with SPECT myocardial perfusion imaging: An additional parameter of adverse cardiac remodeling.
    J Nucl Cardiol. 2017 Jan 12. doi: 10.1007/s12350-017-0777.
    PubMed     Text format     Abstract available


    J Nucl Med

  36. AFSHAR-OROMIEH A, Sattler LP, Mier W, Hadaschik B, et al
    The clinical impact of additional late PET/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183483. doi: 10.2967/jnumed.116.183483.
    PubMed     Text format     Abstract available

  37. ARAKAWA Y, Nai Y, Shidahara M, Furumoto S, et al
    Prediction of the clinical standardized uptake value ratio in amyloid PET imaging using a biomathematical modeling approach towards the efficient development of a radioligand.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183566. doi: 10.2967/jnumed.116.183566.
    PubMed     Text format     Abstract available

  38. SVIRYDENKA H, Delso G, Barbosa FG, Huellner MW, et al
    The effect of susceptibility artifacts related to metal implants on adjacent lesion assessment in simultaneous TOF PET/MR.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.180802. doi: 10.2967/jnumed.116.180802.
    PubMed     Text format     Abstract available

  39. ADAMS HJ, Kwee TC
    Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.187815. doi: 10.2967/jnumed.116.187815.
    PubMed     Text format    

  40. ZHOU X, Boellaard R, Ishiwata K, Sakata M, et al
    In vivo evaluation of [11C]preladenant for PET-imaging of adenosine A2A receptors in the conscious monkey.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.182410. doi: 10.2967/jnumed.116.182410.
    PubMed     Text format     Abstract available


  41. SNMMI COR Submits Recommendations, White Paper on Compounded Sterile Radiopharmaceuticals to USP.
    J Nucl Med. 2017;58:16N-17N.
    PubMed     Text format    

  42. SCHWARZ SW
    SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
    J Nucl Med. 2017;58:20N.
    PubMed     Text format    

  43. CZERNIN J
    Molecular Imaging and Therapy with a Purpose: A Renaissance of Nuclear Medicine.
    J Nucl Med. 2017;58:21A-22A.
    PubMed     Text format    

  44. CHEN DL, Cheriyan J, Chilvers E, Choudoury G, et al
    Quantification of Lung PET Images: Challenges and Opportunities.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.184796. doi: 10.2967/jnumed.116.184796.
    PubMed     Text format     Abstract available

  45. VAN ES SC, Brouwers AH, Mahesh SV, Leliveld-Kors AM, et al
    89Zr-bevacizumab PET: Potential Early Read Out for Efficacy of Everolimus in Metastatic Renal Cell Carcinoma Patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.183475. doi: 10.2967/jnumed.116.183475.
    PubMed     Text format     Abstract available

  46. LEBECH AM, Gaardsting A, Loft A, Graff J, et al
    Whole body 18F-FDG PET/CT is superior to CT as first line diagnostic imaging in patients referred with serious non-specific symptoms or signs of cancer: a randomized prospective study of 200 patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.175380. doi: 10.2967/jnumed.116.175380.
    PubMed     Text format     Abstract available

  47. BARRIO M, Czernin J, Fanti S, Ambrosini V, et al
    The impact of SSTR-directed PET/CT on the management of patients with neuroendocrine tumor: A systematic review and meta-analysis.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.185587. doi: 10.2967/jnumed.116.185587.
    PubMed     Text format     Abstract available


    Nuklearmedizin

  48. SINGH G, Gott MD, Pietzsch HJ, Stephan H, et al
    Nuclear and optical dual-labelled imaging agents. Design and challenges.
    Nuklearmedizin. 2016;55:41-50.
    PubMed     Text format     Abstract available

  49. BRAUER A, Rahbar K, Konnert J, Bogemann M, et al
    Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma.
    Nuklearmedizin. 2017 Jan 11. doi: 10.3413/Nukmed-0846.
    PubMed     Text format     Abstract available


    Phys Med Biol

  50. GILLAM JE, Angelis GI, Kyme AZ, Meikle SR, et al
    Motion compensation using origin ensembles in awake small animal positron emission tomography.
    Phys Med Biol. 2017;62:715-733.
    PubMed     Text format     Abstract available


    PLoS One

  51. KIM HW, Oh M, Oh JS, Oh SJ, et al
    Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PLoS One. 2017;12:e0169928.
    PubMed     Text format     Abstract available

  52. JAUW YW, Zijlstra JM, de Jong D, Vugts DJ, et al
    Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    PLoS One. 2017;12:e0169828.
    PubMed     Text format     Abstract available

  53. PECORI B, Lastoria S, Caraco C, Celentani M, et al
    Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis.
    PLoS One. 2017;12:e0169462.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: